Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Lucira Health Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lucira Health Inc market cap is $4,100.00.
What is the 52-week high for Lucira Health Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lucira Health Inc 52 week high is $1.45 as of October 10, 2025.
What is the 52-week low for Lucira Health Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lucira Health Inc 52 week low is $0.00 as of October 10, 2025.
What is Lucira Health Inc stock price today?
Lucira Health Inc stock price today is $0.0001.
What was Lucira Health Inc stock price yesterday?
Lucira Health Inc stock price yesterday was $0.0001.
What is the PE ratio of Lucira Health Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lucira Health Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Lucira Health Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lucira Health Inc P/B ratio is 0.0001.
What is the 50-day moving average of Lucira Health Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lucira Health Inc 50-day moving average is $0.0003.